Idiopathic chronic and acute recurrent pancreatitis (IP) have been associated with mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Mutations in the serine protease inhibitor Kazal 1 (SPINK1) have been described in some idiopathic chronic patients and it has been suggested that mutations in this gene could be responsible for a loss of trypsin inhibitor function. In this study, the 5 0 UTR region, and the four exons and exon -intron boundaries of the SPINK1 gene in 32 IP patients have been analyzed. Three IP patients (9.3%) and one control/100 carried the N34S mutation of the SPINK1 gene (Fisher's exact test, P ¼ 0.044) . No other mutation that could be associated with an altered function of the SPINK1 protein was observed. The N34S mutation was present in two patients who carried the CFTR-IVS8 5T variant and in one who carried the L997F variant in the CFTR gene. The association of SPINK1 with CFTR gene mutations in IP patients is statistically significant (3/32 IP cases and 0/100 control individuals carrying mutations in both genes; Fisher's exact test P ¼ 0.01).
Introduction
Chronic pancreatitis (CP) is a continuing or relapsing inflammatory disease of the pancreas. CP follows recurrent attacks of acute pancreatitis with all of the common complications of CP, including unrelenting pain, parenchymal and ductal calcifications, duct distortion, fibrosis, maldigestion, and diabetes mellitus. The etiological factor of about one-third of chronic and acute recurrent pancreatitis patients is unknown and this group of patients is classified as suffering from idiopathic pancreatitis (IP). Mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene have been associated with IP. 1 -4 Active trypsin is inhibited by trypsin inhibitors as serine protease inhibitor Kazal type 1 (SPINK1), and when trypsin activity exceeds the inhibitor effect of SPINK1 it will continue to activate trypsinogen and other zymogens, leading to autodigestion of the pancreas and pancreatitis. Mutations in the SPINK1 gene have been reported in hereditary and idiopathic acute and chronic pancreatitis. carried the N34S mutation in the SPINK1 gene. The aim of this study was to search for mutations in the SPINK1 gene in association with susceptibility to IP in Italian patients and to study the possibility of a synergistic effect between SPINK1 and CFTR gene mutations in IP.
Patients and methods

Cases and controls
The population under study consisted of 32 IP Italian subjects (18 males, 14 females, mean age 34.6 years, range 7 -59 years), suffering from either idiopathic chronic pancreatitis (17) or recurrent acute pancreatitis (15) . The criteria for diagnosis were as follows: for idiopathic recurrent pancreatitis, multiple episodes of usually clinical mild pancreatitis in the absence of the etiological factors most commonly associated with pancreatitis such as colelithiassis, alcohol abuse, pancreas divisum, hypercalcemia, dyslipidemia and viral infections; and for idiopathic chronic pancreatitis: progressive pancreatic inflammatory disease characterized by irreversible morphological changes and typically causing pain and/or permanent loss of function, where none of the possible causes previously mentioned in the other definitions had been detected. A total of 50 control individuals from the same Italian population were analyzed in this study. Mutation N34S was tested in a total of 100 control individuals. The patients had been previously analyzed for mutations in the CFTR gene. 8, 9 DNA extraction and analysis DNA was extracted from peripheral blood leukocytes by standard procedures.
Mutation N34S of the SPINK1 gene was detected by PCR with modified primers that produce a restriction site during in vitro amplification (RG-PCR) 10 using forward primer 5 0 CAATCACAGTTATTCCCCAG3 0 , and modified reverse primer 5 0 TGGTGCATCCATTAAGTGCA3 0 which creates a restriction site for endonuclease Bsp1286 I when allele 34S is present. Digestion products were analyzed by 8% acrylamide gel electrophoresis.
The 5 0 UTR region, the four exons and the exon -intron boundaries of the SPINK1 gene were amplified as described 11 and denaturing gradient gel electrophoresis (DGGE) analysis of the amplified fragments was performed. Amplified fragments showing an altered migration pattern were directly sequenced using the BigDye terminator Cycle Sequencing kit (Perkin -Elmer) on a 377 ABI PRISM sequencer.
Results and discussion
Mutation N34S was tested in 32 IP, and 100 control individuals. The mutation was present in three IP patients, one of whom was homozygous, and in one control individual (Fisher's exact test, P ¼ 0.044) ( Table 1) . The four exons and exon -intron boundaries, and the 5'UTR region of the SPINK1 gene were screened for sequence variations by DGGE analysis in 32 cases of IP, and in 50 control individuals. In the 5 0 UTR region, polymorphism À253T4C and the À41G4A variant were found. The common polymorphism À253T4C was present in both groups with similar frequencies and the À41G4A variant was present in one IP patient only. In IVS1, variant À37T4C was observed in three IP patients, and it was in linkage disequilibrium with mutation N34S in exon 3. Beside the N34S mutation, we found the following in exon 3 and boundaries: variant 174C4T(C58C) in one IP patient, variants IVS2À23A4T in two controls, and a novel sequence variant IVS3+12T4G in one IP patient. In exons 1 and 4 and their exon -intron boundaries, no sequence alteration was observed. All the DNA variants detected in this study as well as their distribution in both study groups are summarized in Table 2 .
Four sequence variations were found in IP patients, and of these only the N34S mutation, which was present in three patients (9.3%), has previously been considered as being associated with IP. This result is similar to that reported by Audrézet et its relevance in IP remains to be determined. Interestingly, the N34S mutation was present in two patients who carried the 5T variant and in one who carried the L997F variant in the CFTR gene ( Table 2 ). The patients carrying one CFTR gene and one SPINK1 gene mutation had no family history of IP. No relatives were available for a segregation study of the mutations. The 5T variant of the CFTR gene is one of the three known alleles with a variant number of thymidines (5,7 or 9) in a polythymidyl tract (T-tract) of the acceptor splice site in intron 8. The variant 5T is associated with low amounts of normally processed mRNA 13 and, although this allele does not cause CF, it can modify the phenotypic effect of other mutations. 14 It can be hypothesized that the added action of a lower level of correctly processed CFTR gene product, together with an altered function of the SPINK1 gene product, could have a deleterious effect upon the pancreatic phenotype. A high frequency of the L997F mutation of the CFTR gene has been described in our cohort of IP patients 8 and it has been postulated that this mutation, together with other CFTR gene mutations, can cause IP as an atypical, monosymptomatic form of CF. As with the 5T variant, it can be hypothesized that the L997F mutation combined with a SPINK1 mutation can have a synergistic effect upon the development of IP. IP patients carrying a SPINK1 mutation as well as a CFTR gene mutation have also been reported by were not identified in this study, possibly because of the low number of observations. Our observation suggests a possible interaction of CFTR and SPINK1 gene variants in determining IP. 
